Vera Therapeutics (VERA) Other Non-Current Assets (2021 - 2026)
Vera Therapeutics (VERA) posted Other Non-Current Assets of $1.2 million for Q1 2026, down 80.17% on a QoQ basis from $5.8 million in Q4 2025, and up 917.54% year-over-year from $114000.0 in Q1 2025.
Vera Therapeutics (VERA) Other Non-Current Assets (2021 - 2026) Analysis & Trends
Vera Therapeutics' Other Non-Current Assets history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- Quarterly Other Non-Current Assets rose 917.54% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 917.54% YoY) and the FY2025 annual result came in at $5.8 million, up 4365.65% from the prior year.
- Other Non-Current Assets was $1.2 million for Q1 2026 at Vera Therapeutics, down from $5.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $5.8 million in Q4 2025 and bottomed at $67000.0 in Q1 2022.
- A 5-year average of $1.0 million and a median of $460000.0 in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 77.13% — and 2025, when it surged 4365.65%.
- Vera Therapeutics' Other Non-Current Assets stood at $293000.0 in 2022, then jumped by 64.51% to $482000.0 in 2023, then slumped by 72.82% to $131000.0 in 2024, then jumped by 4365.65% to $5.8 million in 2025, then sank by 80.17% to $1.2 million in 2026.
- Business Quant data shows VERA's Other Non-Current Assets at $1.2 million in Q1 2026, $5.8 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 5.85 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 114,000.00 |
| Dec 31, 2024 | 131,000.00 |
| Sep 30, 2024 | 140,000.00 |
| Jun 30, 2024 | 460,000.00 |
| Mar 31, 2024 | 473,000.00 |
| Dec 31, 2023 | 482,000.00 |
| Sep 30, 2023 | 470,000.00 |
| Jun 30, 2023 | 465,000.00 |
| Mar 31, 2023 | 293,000.00 |
| Dec 31, 2022 | 293,000.00 |
| Sep 30, 2022 | 149,000.00 |
| Jun 30, 2022 | 82,000.00 |
| Mar 31, 2022 | 67,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 293,000.00 |
| Jun 30, 2021 | 293,000.00 |